Literature DB >> 23725813

Baicalin pretreatment protects against myocardial ischemia/reperfusion injury by inhibiting mitochondrial damage-mediated apoptosis.

Xianbao Wang1, Fei He, Yulin Liao, Xudong Song, Min Zhang, Lingling Qu, Tao Luo, Shanshan Zhou, Yuanna Ling, Jingbin Guo, Aihua Chen.   

Abstract

Entities:  

Keywords:  Apoptosis; Baicalin; Mitochondrial damage; Myocardial reperfusion injury

Mesh：

Substances：

Year:  2013        PMID： 23725813     DOI： 10.1016/j.ijcard.2013.05.077

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  5 in total

1.  Suppression of Stim1 reduced intracellular calcium concentration and attenuated hypoxia/reoxygenation induced apoptosis in H9C2 cells.

Authors:  Fei He; Qianfu Wu; Banglong Xu; Xiaocheng Wang; Jixiong Wu; Li Huang; Jing Cheng
Journal:  Biosci Rep       Date:  2017-11-23       Impact factor: 3.840

2.  Klotho overexpression suppresses apoptosis by regulating the Hsp70/Akt/Bad pathway in H9c2(2-1) cells.

Authors:  Jinpeng Hu; Bin Su; Xuewen Li; Yuming Li; Jihong Zhao
Journal:  Exp Ther Med       Date:  2021-03-16       Impact factor: 2.447

3.  Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis.

Authors:  Zhenyu Fan; Liangliang Cai; Shengnan Wang; Jing Wang; Bohua Chen
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

4.  Acute myocardial infarction therapy: in vitro and in vivo evaluation of atrial natriuretic peptide and triphenylphosphonium dual ligands modified, baicalin-loaded nanoparticulate system.

Authors:  Jie Wang; Shouwen Zhang; Lizhe Di
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  An Integrated Approach Based on Network Analysis Combined With Experimental Verification Reveals PI3K/Akt/Nrf2 Signaling Is an Important Way for the Anti-Myocardial Ischemia Activity of Yi-Qi-Tong-Luo Capsule.

Authors:  Huxinyue Duan; Meiyan Li; Jia Liu; Jiayi Sun; Chunjie Wu; Yu Chen; Xiaohui Guo; Xinglong Liu
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.